Biocon Stock Screener | Share Price & Fundamental Analysis
BIOCON
Pharmaceuticals
Share Price NSE
₹383.95
▲
1.30 (0.34%)
Share Price BSE
₹383.95
▲
1.75 (0.46%)
Track Biocon share price live with TickJournal's free stock screener.
Analyze Biocon share price history trends and compare 52-week high low
levels.
Calculate BIOCON stock fair value using fundamental analysis and view live share price charts.
Determine Biocon share intrinsic value and compare it with current BIOCON share price.
Record your Biocon trades in TickJournal's free trading journal and track your portfolio performance.
Biocon Market Cap
₹61,651.23 Cr.
BIOCON P/E Ratio (TTM)
97.37
Biocon P/B Ratio
1.62
EPS (TTM)
₹8.46
Dividend Yield
0.10%
Debt to Equity
0.84
BIOCON 52 Week High
₹421.60
Biocon 52 Week Low
₹302.45
Operating Margin
23.00%
Profit Margin
10.40%
BIOCON Revenue (TTM)
₹4,415.00
EBITDA
₹1,077.00
Net Income
₹459.00
Total Assets
₹58,797.00
Total Equity
₹27,713.00
Biocon Share Price History - Stock Screener Chart
Screen BIOCON historical share price movements with interactive charts. Analyze price trends and patterns.
Biocon Company Profile - Fundamental Screener
Screen Biocon company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for BIOCON shares.
Biocon Limited is India's largest fully-integrated biopharmaceutical company, focusing on biotechnology products and research services. Founded in 1978, Biocon specializes in treating diabetes, cancer, and autoimmune diseases. The company develops and commercializes novel biologics, biosimilars, complex small molecule APIs, and generic formulations for global markets. Biocon's product portfolio includes cardiology,...more
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
Chairperson/CEO
Kiran Mazumdar Shaw
ISIN
INE376G01013
Website
https://www.biocon.com
Biocon Balance Sheet Screener
Screen BIOCON balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 58,797 | 56,071 | 52,043 | 20,394 | 18,522 | 14,444 | 12,192 | 9,990 | 9,394 | 8,458 |
| Current Assets | 16,286 | 15,179 | 12,334 | 8,382 | 7,600 | 5,325 | 4,823 | 4,149 | 4,048 | 3,971 |
| Fixed Assets | 31,963 | 30,644 | 29,468 | 6,569 | 6,364 | 5,971 | 4,471 | 3,700 | 3,626 | 1,749 |
| Liabilities | ||||||||||
| Total Liabilities | 58,797 | 56,071 | 52,043 | 20,394 | 18,522 | 14,444 | 12,192 | 9,990 | 9,394 | 8,458 |
| Current Liabilities | 16,751 | 15,437 | 21,043 | 7,096 | 5,805 | 3,053 | 2,448 | 2,200 | 2,502 | 2,493 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 27,713 | 25,275 | 22,489 | 9,470 | 8,508 | 7,383 | 6,707 | 5,649 | 5,214 | 4,300 |
| Share Capital | 600 | 600 | 600 | 600 | 600 | 600 | 300 | 300 | 100 | 100 |
| Reserves & Surplus | 21,044 | 19,183 | 17,267 | 7,832 | 7,027 | 6,106 | 5,798 | 4,881 | 4,738 | 3,992 |
Biocon Income Statement Screener - Profit & Revenue Analysis
Screen Biocon income statement and profit fundamentals.
Analyze BIOCON quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Biocon share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4,415 | 3,990 | 4,356 | 4,240 | 3,912 | 4,543 | 3,604 | 3,826 | 3,929 | 3,516 | 3,551 | 4,135 | 2,476 | 2,217 | 2,384 |
| Expenses | 3,339 | 3,193 | 3,472 | 3,633 | 3,013 | 2,813 | 2,905 | 3,070 | 2,820 | 2,741 | 2,769 | 3,051 | 1,911 | 1,783 | 1,894 |
| EBITDA | 1,077 | 797 | 884 | 607 | 900 | 1,730 | 699 | 756 | 1,109 | 775 | 782 | 1,084 | 565 | 434 | 490 |
| Operating Profit % | 23.00% | 18.00% | 19.00% | 12.00% | 22.00% | 17.00% | 18.00% | 19.00% | 25.00% | 20.00% | 18.00% | 14.00% | 21.00% | 17.00% | 18.00% |
| Depreciation | 436 | 455 | 473 | 515 | 407 | 405 | 420 | 425 | 364 | 358 | 389 | 415 | 212 | 218 | 231 |
| Interest | 212 | 277 | 272 | 210 | 227 | 236 | 226 | 223 | 249 | 233 | 248 | 267 | 11 | 20 | 30 |
| Profit Before Tax | 487 | 97 | 171 | -68 | 319 | 1,146 | 98 | 156 | 497 | 184 | 214 | 808 | 343 | 197 | 229 |
| Tax | 27 | 8 | 39 | -16 | 96 | 284 | 71 | 75 | 82 | 35 | 42 | 55 | 59 | 30 | 147 |
| Net Profit | 459 | 89 | 133 | -52 | 223 | 862 | 27 | 81 | 415 | 149 | 173 | 753 | 284 | 167 | 82 |
| EPS | 2.88 | 0.26 | 0.66 | 1.08 | 1.13 | 5.51 | -0.13 | 0.21 | 2.62 | 0.85 | 1.05 | 5.52 | 2.00 | 1.21 | 0.39 |
Biocon Cash Flow Screener - Liquidity Fundamentals
Screen BIOCON cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 4,061 | 2,954 | 1,853 | 1,177 | 1,160 | 1,283 | 1,155 | 662 | 640 | 371 |
| Investing Activities | -203 | -1,002 | -14,260 | -1,662 | -3,651 | -1,505 | -703 | -684 | -510 | -1,138 |
| Financing Activities | -1,854 | -2,333 | 13,049 | 242 | 2,564 | 388 | -242 | -240 | -178 | 1,068 |
| Net Cash Flow | 2,004 | -380 | 641 | -243 | 72 | 165 | 210 | -261 | -47 | 300 |
Biocon Shareholding Pattern Screener
See Biocon shareholding pattern with promoter, FII, and DII holdings.
Check Biocon promoter holding and ownership changes for BIOCON on TickJournal.
| Item | 2026-Jan | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 44.91% | 60.64% | 54.45% | 54.45% | 54.45% | 60.64% | 60.64% | 60.64% |
| FII Holding | 7.14% | 5.66% | 6.04% | 6.61% | 7.39% | 5.63% | 5.90% | 5.93% |
| DII Holding | 24.16% | 15.72% | 22.82% | 22.10% | 21.71% | 13.68% | 14.30% | 14.44% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 10.23% | 13.63% | 12.58% | 12.71% | 12.38% | 15.53% | 14.63% | 14.57% |
| Other Holding | 13.55% | 4.34% | 4.10% | 4.12% | 4.06% | 4.52% | 4.53% | 4.42% |
| Shareholder Count | 394,215 | 424,297 | 430,217 | 413,191 | 394,279 | 470,261 | 443,513 | 439,503 |
Biocon Share Dividend Screener - Share Yield Analysis
Check Biocon dividend history with payout and yield data.
View Biocon dividend details including ex-dates and amounts for BIOCON stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.50 | 0.13% |
| 2024-March | ₹0.50 | 0.15% |
| 2023-March | ₹1.50 | 0.57% |
| 2022-March | ₹0.50 | 0.25% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹1.00 | 0.37% |
| 2018-March | ₹1.00 | 0.33% |
| 2017-March | ₹3.00 | 1.01% |
Biocon Stock Index Membership
See which indices include Biocon stock.
Check BIOCON index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Biocon Market Events Screener - Corporate Actions
Get Biocon corporate actions including splits, bonuses, and buybacks.
Check Biocon stock events that may affect BIOCON share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-12-31 | 2026-12-31 | Extraordinary General Meeting | NA | -0.61% |
| 2026-02-12 | 2026-02-12 | Quarterly Result Announcement | NA | 1.08% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 8.49% |
| 2025-08-08 | 2025-08-08 | Annual General Meeting | NA | 5.11% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -3.08% |
| 2025-07-04 | 2025-07-04 | Dividend | ₹ 0.50 /share | 8.05% |
| 2025-05-08 | 2025-05-08 | Quarterly Result Announcement | NA | 2.18% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | -4.63% |
| 2024-10-30 | 2024-10-30 | Quarterly Result Announcement | NA | -11.82% |
| 2024-08-09 | 2024-08-09 | Annual General Meeting | NA | 8.75% |
| 2024-07-05 | 2024-07-05 | Dividend | ₹ 0.50 /share | 15.77% |
| 2023-07-07 | 2023-07-07 | Dividend | ₹ 1.50 /share | 7.92% |
| 2022-06-30 | 2022-07-01 | Dividend | ₹ 0.50 /share | -19.33% |
| 2019-06-12 | 2019-06-13 | Bonus | 1:1 | -4.99% |
Biocon Competitors Screener - Peer Comparison
Screen BIOCON competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 408,007 | 37.20 | 54,729 | 9.71% | 10,980 | 53.25 |
| Divis Laboratories | 163,250 | 66.07 | 9,712 | 18.67% | 2,191 | 48.15 |
| Torrent Pharmaceuticals | 144,229 | 64.43 | 11,539 | 6.99% | 1,911 | 70.35 |
| Cipla | 109,566 | 23.71 | 28,410 | 7.12% | 5,291 | 45.95 |
| Dr Reddys Laboratories | 105,948 | 19.16 | 33,741 | 16.73% | 5,725 | 58.53 |
| Lupin | 101,478 | 21.52 | 22,910 | 13.74% | 3,306 | 60.82 |
| Zydus Life Science | 91,613 | 18.12 | 23,511 | 18.55% | 4,615 | 52.96 |
| Mankind Pharma | 86,000 | 47.17 | 12,744 | 20.90% | 2,007 | 45.43 |
| Aurobindo Pharma | 68,802 | 19.14 | 32,346 | 9.43% | 3,484 | 51.95 |
| Alkem Laboratories | 65,528 | 26.80 | 13,458 | 3.70% | 2,216 | 40.44 |
Biocon Company Announcements - News Screener
Screen BIOCON latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-18 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-02-18 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-02-17 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2026-02-17 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-02-17 | Outcome Of Board Meeting - In-Principle Approval Of Acquisition | View |
| 2026-02-17 | Outcome Of Board Meeting | View |
| 2026-02-17 | Board Meeting Outcome for Outcome Of Board Meeting- Quarterly Results | View |
| 2026-02-17 | Outcome Of Board Meeting-Financial Results | View |
| 2026-02-12 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-30 | Buyback Of Commercial Papers | View |
| 2026-01-28 | Intimation Of Record Date For Buy Back Of Listed Commercial Paper Issued By The Company | View |
| 2026-01-28 | Intimation Of Record Date For Buy Back Of Listed Commercial Paper Issued By The Company | View |
| 2026-01-28 | Notification To Stock Exchanges | View |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-21 | Certificate Pursuant To SEBI Master Circular No. SEBI/HO/DDHS/Ddhspod/ P/CIR/2025/0000000137 Dated October 15 2025 | View |
| 2026-01-21 | Announcement under Regulation 30 (LODR)-Updates on Acquisition | View |
| 2026-01-20 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2026-01-15 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-14 | Announcement under Regulation 30 (LODR)-Allotment | View |